Department of Orthopedics, Hospital for Special Surgery, New York, NY.
J Arthroplasty. 2022 Aug;37(8):1626-1630. doi: 10.1016/j.arth.2022.03.057. Epub 2022 Mar 19.
There is a relative paucity of literature on the outcomes after revision total hip arthroplasty (rTHA) in young patients. This study reports the survivorship and risk factors for re-revision in patients aged ≤55 years.
We identified 354 patients undergoing aseptic nononcologic rTHA at mean follow-up of 5 years after revision, with mean age of 48 years, body mass index of 28 kg/m, and 64% female. Thirty-five (10%) patients underwent at least 1 previous rTHA. The main indications for rTHA included wear/osteolysis (21%), adverse local tissue reaction (21%), recurrent instability (20%), acetabular loosening (16%), and femoral loosening (7%); and included acetabular component-only rTHA in 149 patients (42%), femoral component-only rTHA in 46 patients (13%), both component rTHA in 44 patients (12%), and head/liner exchanges in patients 115 (33%). The Kaplan-Meier method was used to measure survivorship free from re-revision THA, and multivariate regression was used to identify risk factors for re-revision THA.
Sixty-two patients (18%) underwent re-revision THA at the mean time of 2.5 years, most commonly for instability (37%), aseptic loosening (27%), and prosthetic joint infection (15%). The rTHA survivorship from all-cause re-revision and reoperation was 83% and 79% at 5 years, respectively. Multivariate analysis demonstrated that patients undergoing femoral component only (hazard ratio 4.8, P = .014) and head/liner exchange rTHA (hazard ratio 2.5, P = .022) as risk factors for re-revision THA.
About 1 in 5 patients aged ≤55 years undergoing rTHA required re-revision THA at 5 years, most commonly for instability. The highest risk group included patients undergoing head/liner exchanges and isolated femoral component revisions.
关于年轻患者接受翻修全髋关节置换术(rTHA)后的结果,文献相对较少。本研究报告了≤55 岁患者的翻修后生存率和再翻修的风险因素。
我们在平均 5 年的随访后,共确定了 354 例接受无菌非肿瘤性 rTHA 的患者,平均年龄为 48 岁,体重指数为 28kg/m,女性占 64%。35 例(10%)患者至少接受过 1 次 rTHA。rTHA 的主要指征包括磨损/骨溶解(21%)、局部组织不良反应(21%)、复发性不稳定(20%)、髋臼松动(16%)和股骨松动(7%);髋臼组件翻修仅 149 例(42%),股骨组件翻修仅 46 例(13%),同时翻修组件 44 例(12%),115 例(33%)行头/衬垫置换。Kaplan-Meier 法用于测量无再翻修 THA 的生存率,多变量回归用于识别再翻修 THA 的风险因素。
62 例(18%)患者在平均 2.5 年内接受了再翻修 THA,最常见的原因是不稳定(37%)、无菌性松动(27%)和假体关节感染(15%)。rTHA 因所有原因再翻修和再手术的 5 年生存率分别为 83%和 79%。多变量分析表明,仅行股骨组件翻修(风险比 4.8,P=0.014)和行头/衬垫置换 rTHA(风险比 2.5,P=0.022)是再翻修 THA 的风险因素。
在接受 rTHA 的≤55 岁患者中,约有 1/5 在 5 年内需要再次接受 THA,最常见的原因是不稳定。风险最高的组包括行头/衬垫置换和单纯股骨组件翻修的患者。